India Edwards

1 week ago | upi.com | India Edwards

Consuming too much cinnamon might affect how your body absorbs some medications, new research shows. The study, published in the June issue of the journal Food Chemistry: Molecular Sciences, looked at how cinnamon and its key ingredients affect the way the body processes drugs, The Washington Post reported. While small amounts of cinnamon can offer health benefits, researchers say using it too often or in high amounts may lead to drug interactions.

3 weeks ago | upi.com | India Edwards

A quick spray of medication might seem like an easy way to get thicker hair, but some people say one sold online has left them battling sexual side effects, depression and even thoughts of suicide. Now, the U.S. Food and Drug Administration is warning the public about the risks. The FDA warning is about a topical spray version of finasteride, a drug often sold online by telehealth companies like Hims, Keeps and Ro, The Wall Street Journal reported.

1 month ago | upi.com | India Edwards

A newly approved antibiotic to treat urinary tract infections may also help fight drug-resistant gonorrhea, a new study shows. The medication, called gepotidacin, could become the first new gonorrhea treatment since the 1990s. In an international study of more than 600 people, researchers found that it worked just as well as current standard treatments.

1 month ago | miamiherald.com | India Edwards

As a measles outbreak spreads across the United States, doctors are now seeing a new and unexpected danger: children getting sick from taking too much vitamin A. At Covenant Children's Hospital in Lubbock, Texas, several unvaccinated children showed signs of liver problems after taking large amounts of vitamin A, according to Dr. Lara Johnson, the hospital's chief medical officer. U.S. Department of Health and Human Services Secretary Robert F.

1 month ago | upi.com | India Edwards

In one study, Alnylam Pharmaceuticals' Amvuttra helped lower the risk of death and heart problems by 28% over three years compared to a placebo. The drug is given as a shot every three months. Adobe stock/HealthDay The U.S. Food and Drug Administration has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra (vutrisiran), is made by Alnylam Pharmaceuticals Inc. and is used to treat transthyretin amyloid cardiomyopathy.